Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
07 09 2020
07 09 2020
Historique:
received:
08
08
2019
accepted:
30
06
2020
entrez:
8
9
2020
pubmed:
9
9
2020
medline:
12
3
2021
Statut:
epublish
Résumé
Clostridioides difficile (C.difficile) is a Gram-positive, spore-forming, toxin-producing anaerobic bacillus, which is one of the most common causes of health-care-associated infection developed mainly by elderly patients. The objective of this study was to assess mortality among the patients of the Hospital for Infectious Diseases in Warsaw related to C.difficile infection. Analysis was conducted of 1638 records reporting the medical histories of patients hospitalized for the first time due to Clostridioides difficile infection (CDI) in the Hospital for Infectious Diseases in Warsaw from 2010 to 2017. The inclusion criteria were any (principal or secondary) discharge diagnosis code for CDI according to ICD-10 and being an adult (≥ 18 years). 108 out of 1638 (7%) of the patients died. The median age in this group was 83 years. The largest number of deaths (90%) occurred in the group of patients aged 65 years or older and 81-90 years old (53% of all the deaths). In the multivariate logistic regression model relevant only to the age groups, not to sepsis-age over 80 and over 90 were independent predictors of death, increasing the risk of death by 3.4 and 1.8 times, respectively. The result of the receiver operating curve (ROC) analysis determined the age of 77 years as the threshold value, indicating the increased risk of death (AUC 0.727, standard error 0.025, 95% CI 0.678-0.776, p < 0.0001). In addition, other quantitative variables, namely CRP, creatinine and leucocytes were studied and turned out to be independent death predictors as well. The diagnosis of sepsis increased the risk of death fourfold (OR = 4.042; 95% Cl 2.4-6.7; p < 0.001). Increased inflammatory parameters, namely CRP and white blood cell count, advanced age, particularly over the age of 80, as well as a diagnosis of sepsis are independent risk factors for death and could be used as predictive markers of poor outcome in CDI.
Identifiants
pubmed: 32895405
doi: 10.1038/s41598-020-71466-0
pii: 10.1038/s41598-020-71466-0
pmc: PMC7477561
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
14681Références
Kasper, D. L. & Fauci, A. S. Harrison’s Infectious Diseases 3rd edn. (McGraw-Hill Education, New York, 2017).
Abou Chakra, C. N. et al. Factors associated with complications of Clostridium difficile infection in a multicenter prospective cohort. Clin. Infect. Dis. 61, 1781–1788 (2015).
doi: 10.1093/cid/civ749
Magill, S. S. et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N. Engl. J. Med. 379, 1732–1744 (2018).
doi: 10.1056/NEJMoa1801550
Khanna, S., Pardi, D. S., Aronson, S. L., Kammer, P. P. & Baddour, L. M. Outcomes in community-acquired Clostridium difficile infection. Aliment Pharmacol. Ther. 35, 613–618 (2012).
doi: 10.1111/j.1365-2036.2011.04984.x
Sailhamer, E. A. et al. Fulminant Clostridium difficile colitis: Patterns of care and predictors of mortality. Arch. Surg. 144, 433–439 (2009).
doi: 10.1001/archsurg.2009.51
Reacher, M. et al. Excess mortality attributable to Clostridium difficile and risk factors for infection in an historic cohort of hospitalised patients followed up in the United Kingdom death register. PLoS ONE 11, 0149983 (2016).
doi: 10.1371/journal.pone.0149983
Debast, S. B., Bauer, M. P., Kuijper, E. J. & European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin. Microbiol. Infect. 20, 1–26 (2014).
doi: 10.1111/1469-0691.12418
Bloomfield, M. G., Sherwin, J. C. & Gkrania-Klotsas, E. Risk factors for mortality in Clostridium difficile infection in the general hospital population: a systematic review. J. Hosp. Infect. 82, 1–12 (2012).
doi: 10.1016/j.jhin.2012.05.008
McDonald, L. C. et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin. Infect. Dis. 66, 987–994 (2018).
doi: 10.1093/cid/ciy149
Hanley, J. A. & McNeil, B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29–36 (1982).
doi: 10.1148/radiology.143.1.7063747
Bauer, M. P. et al. Clostridium difficile infection in Europe: A hospital-based survey. Lancet 377, 63–73 (2011).
doi: 10.1016/S0140-6736(10)61266-4
Lee, E. et al. Risk factors for poor outcome in community-onset Clostridium difficile infection. Antimicrob. Resist. Infect. Control. 7, 75 (2018).
doi: 10.1186/s13756-018-0365-6
Pechal, A., Lin, K., Allen, S. & Reveles, K. National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals. BMC Infect. Dis. 16, 682 (2016).
doi: 10.1186/s12879-016-2027-8
Patel, U., Wieczorkiewicz, J. & Tuazon, J. Evaluation of advanced age as a risk factor for severe Clostridium difficile infection. J. Clin. Gerontol. Geriatr. 7, 12–16 (2016).
doi: 10.1016/j.jcgg.2015.06.003
Morrison, R. H. et al. Risk factors associated with complications and mortality in patients with Clostridium difficile infection. Clin. Infect. Dis. 53, 1173–1178 (2011).
doi: 10.1093/cid/cir668
Solomon, K. et al. Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. J. Med. Microbiol. 62, 1453–1460 (2013).
doi: 10.1099/jmm.0.058479-0
Sheldon, J., Riches, P., Gooding, R., Soni, N. & Hobbs, J. R. C-reactive protein and its cytokine mediators in intensive-care patients. Clin. Chem. 39, 147–150 (1993).
doi: 10.1093/clinchem/39.1.147
Sproston, N. R. & Ashworth, J. J. Role of C-reactive protein at sites of inflammation and infection. Front. Immunol. 9, 754 (2018).
doi: 10.3389/fimmu.2018.00754
Haran, J. P., Beaudoin, F. L., Suner, S. & Lu, S. C-reactive protein as predictor of bacterial infection among patients with an influenza-like illness. Am. J. Emerg. Med. 31, 137–144 (2013).
doi: 10.1016/j.ajem.2012.06.026
Chousterman, B. G., Swirski, F. K. & Weber, G. F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 39, 517–528 (2017).
doi: 10.1007/s00281-017-0639-8
Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801–810 (2016).
doi: 10.1001/jama.2016.0287